Carregant...
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on ag...
Guardat en:
| Publicat a: | Hosp Pharm |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Thomas Land Publishers, Inc.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567207/ https://ncbi.nlm.nih.gov/pubmed/26405327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5005-396 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|